Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
potassium chloride + sodium gluconate + magnesium chloride + sodium acetate + sodium chloride is a balanced intravenous crystalloid combination product used for parenteral fluid and electrolyte replacement. It contains sodium, potassium, magnesium, chloride, acetate, and gluconate in concentrations designed to approximate plasma electrolyte composition and support restoration or maintenance of extracellular fluid volume. Its pharmacologic effect is not mediated through a discrete receptor target; rather, it replenishes body water and essential electrolytes, while acetate and gluconate are metabolized to bicarbonate precursors that can help buffer metabolic acidosis. The product is used in settings such as dehydration, hypovolemia, perioperative care, trauma, and critical illness, and is marketed in branded presentations including Normosol-R, Plasma-Lyte A, and Isolyte S.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium gluconate + magnesium chloride + sodium acetate + sodium chloride.